ZNF513

Across TCGA pan-cancer cohorts, ZNF513 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated ZNF513 data layer compared with 19 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher ZNF513 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF513 expression acts as an unfavorable survival marker, although some lineages such as UCEC and HNSC show a favorable association.

LUAD, UCEC, and HNSC are the cancer types where ZNF513 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.311	0.813	.001	49	view →
UCEC	DFS	Quartile	All	1.000	0.688	.018	30	view →
HNSC	DFS	Median	II,III,IV	1.000	0.734	.038	1	view →
LSCC	OS	Tertile	All	0.945	0.712	.038	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

ZNF513–LUAD (DFS)

Open the LUAD breakdown →